Mutant-flu paper published

Nature

Volumn 485, Issue 7396, 2012, Pages 13-14

  Yong, Ed ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINE; ASPARTIC ACID; GLUTAMINE; INFLUENZA VACCINE; LEUCINE; LYSINE; OSELTAMIVIR; VIRUS HEMAGGLUTININ;

ACCESS TO INFORMATION; CELL SURFACE; DISEASE SURVEILLANCE; HOST CELL; HUMAN; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; MAMMAL CELL; NONHUMAN; NOTE; PRIORITY JOURNAL; RECEPTOR BINDING; TREATMENT OUTCOME; VIRUS HYBRID; VIRUS MUTANT; VIRUS MUTATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; BIOTERRORISM; BIRDS; FERRETS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; INTERNATIONAL COOPERATION; MUTATION; PUBLISHING; REASSORTANT VIRUSES; RECEPTORS, VIRUS; RISK ASSESSMENT; SECURITY MEASURES; ZOONOSES;

EID: 84860531885     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/485013a     Document Type: Note

References (4)

1. Imai, M. et al. Nature http://dx.doi.org/10.1038/nature10831 (2012).
2. Watanabe, Y. et al. PLoS Pathog. 7, e1002068 (2011).
3. Octaviani, C. P., Ozawa, M., Yamada, S., Goto, H. & Kawaoka, Y. J. Virol. 84, 10918-10922 (2010).
4. Sorrell, E. M., Wan, H., Araya, Y., Song, H. & Perez, D. R. Proc. Natl Acad. Sci. USA 106, 7565-7570 (2009).